KSR International Co. v. Teleflex Inc.

Global Vascular Closure Devices Market Projected to Reach $1.4 Billion by 2030, Driven by Cardiovascular Health Focus - ResearchAndMarkets.com

Retrieved on: 
Monday, October 9, 2023
Medical Devices, Health, Elixir, Online, Food, Climate change, Developed country, KSR International Co. v. Teleflex Inc., Machine learning, Cardinal Health, Vascular closure device, AI, GDP, Report, Growth, Policy, Access, Pet industry, Video game, Tourism, Renewable energy, Cordis, Euro

The "Vascular Closure Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Vascular Closure Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The global market for Vascular Closure Devices, estimated at US$824.6 million in 2022, is poised for substantial growth, projected to reach a revised size of US$1.4 billion by 2030, with a notable CAGR of 7.3% over the analysis period from 2022 to 2030.
  • Meanwhile, the growth in the Active Approximators segment is estimated at a commendable 6.5% CAGR for the next 8-year period.
  • The U.S. Market is Estimated at $340.6 Million, While China Shows Strong Growth
    In the United States, the Vascular Closure Devices market is estimated at US$340.6 million in 2022.

AI in Pathology Market worth $49 million | MarketsandMarkets

Retrieved on: 
Friday, July 14, 2023
ER, Human, Mayo Clinic, Partnership, KSR International Co. v. Teleflex Inc., Ki-67, Marie Cassidy, AP, Intelligence, Minerva Surgical, Inc. v. Hologic, Inc., Predictive analytics, Verily, HIV disease progression rates, Algorithm, Anomaly, HALO, Artificial intelligence, Knowledge, Clinical professor, AI, Corona Labs Inc., Education, PR, Breast cancer, Cryptocurrency, Medical device, Medical imaging, Pathology

The agreement helped to provide a fully interoperable solution between Indica Labs' HALO AP image management software platform and Lunit's suite of AI pathology products.

Key Points: 
  • The agreement helped to provide a fully interoperable solution between Indica Labs' HALO AP image management software platform and Lunit's suite of AI pathology products.
  • Through this partnership, the company aimed to bring the power of artificial intelligence to digital pathology.
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=86647266
    AI in Pathology Market Advantages:
    Improved Accuracy: AI algorithms can analyze large volumes of medical data with high precision and accuracy.
  • Cost Reduction: By increasing efficiency and accuracy, AI in pathology has the potential to reduce healthcare costs.

AI in Pathology Market worth $49 million | MarketsandMarkets

Retrieved on: 
Friday, July 14, 2023
ER, Human, Mayo Clinic, Partnership, KSR International Co. v. Teleflex Inc., Ki-67, Marie Cassidy, AP, Intelligence, Minerva Surgical, Inc. v. Hologic, Inc., Predictive analytics, Verily, HIV disease progression rates, Algorithm, Anomaly, HALO, Artificial intelligence, Knowledge, Clinical professor, AI, Corona Labs Inc., Education, PR, Breast cancer, Cryptocurrency, Medical device, Medical imaging, Pathology

The agreement helped to provide a fully interoperable solution between Indica Labs' HALO AP image management software platform and Lunit's suite of AI pathology products.

Key Points: 
  • The agreement helped to provide a fully interoperable solution between Indica Labs' HALO AP image management software platform and Lunit's suite of AI pathology products.
  • Through this partnership, the company aimed to bring the power of artificial intelligence to digital pathology.
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=86647266
    AI in Pathology Market Advantages:
    Improved Accuracy: AI algorithms can analyze large volumes of medical data with high precision and accuracy.
  • Cost Reduction: By increasing efficiency and accuracy, AI in pathology has the potential to reduce healthcare costs.

Global Electric Vehicle Battery Market to Reach $84.5 Billion by 2030

Retrieved on: 
Thursday, February 2, 2023
Lithium, Table, Climate change, Hybrid electric vehicle, Investment, Battery, Region, Pressure, Hybrid, Food, Battery electric vehicle, Lead–acid battery, Risk, Electric vehicle battery, EV, Automotive industry, Battery pack, End-use certificate, Growth, Plug, KSR International Co. v. Teleflex Inc., COVID, COVID-19, Type, Plug-in, Lead, Video game, Electric battery, Fireworks, Satellite navigation device, Rare-earth element, Rail freight transport, Cochineal, Beauty salon, Limited

In the changed post COVID-19 business landscape, the global market for Electric Vehicle Battery estimated at US$26.5 Billion in the year 2022, is projected to reach a revised size of US$84.5 Billion by 2030, growing at a CAGR of 15.6% over the analysis period 2022-2030.

Key Points: 
  • In the changed post COVID-19 business landscape, the global market for Electric Vehicle Battery estimated at US$26.5 Billion in the year 2022, is projected to reach a revised size of US$84.5 Billion by 2030, growing at a CAGR of 15.6% over the analysis period 2022-2030.
  • The U.S. Market is Estimated at $7.2 Billion, While China is Forecast to Grow at 21.4% CAGR
    The Electric Vehicle Battery market in the U.S. is estimated at US$7.2 Billion in the year 2022.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$13.1 Billion by the year 2030.
  • Vehicle Sales by Vehicle Type for the Years 2015, 2020, 2025
    Development of EV Charging Infrastructure Drives EV Sales,
    in Billion kWH by Region for the Years 2020, 2025 and 2030
    Falling Prices of EV Batteries: A Positive Development for the
    Automotive Li-ion Battery Packs (US$/kWH) for the Years 2010,
    Management of Thermal Runaway in EV Batteries: Essential to
    Electric Vehicle Battery by Geographic Region - USA, Canada,
    Middle East and Africa Markets for Years 2014, 2023 & 2030
    Lithium ion Battery by Geographic Region - USA, Canada, Japan,
    Middle East and Africa for Years 2014, 2023 & 2030
    Acid Battery by Geographic Region - USA, Canada, Japan, China,
    Middle East and Africa for Years 2014, 2023 & 2030
    Other Types by Geographic Region - USA, Canada, Japan, China,
    Middle East and Africa for Years 2014, 2023 & 2030
    Hybrid Electric Vehicles by Geographic Region - USA, Canada,
    Latin America, Middle East and Africa for Years 2014, 2023 &
    Plug-in Hybrid Electric Vehicles by Geographic Region - USA,
    Vehicles by Geographic Region - USA, Canada, Japan, China,
    Latin America, Middle East and Africa for Years 2014, 2023 &
    Battery Electric Vehicles by Geographic Region - USA, Canada,
    by Geographic Region - USA, Canada, Japan, China, Europe,
    Latin America, Middle East and Africa for Years 2014, 2023 &
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    Type - Lithium ion Battery, Lead Acid Battery and Other Types
    Battery, Lead Acid Battery and Other Types for the Years 2014,
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Electric Vehicles for the Years 2014, 2023 & 2030
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    by Type - Lithium ion Battery, Lead Acid Battery and Other
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    by End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Battery Electric Vehicles for the Years 2014, 2023 & 2030
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    Type - Lithium ion Battery, Lead Acid Battery and Other Types
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Battery Electric Vehicles for the Years 2014, 2023 & 2030
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    Type - Lithium ion Battery, Lead Acid Battery and Other Types
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Battery Electric Vehicles for the Years 2014, 2023 & 2030
    Electric Vehicle Battery by Geographic Region - France,
    by Geographic Region - France, Germany, Italy, UK, Spain,
    Europe Markets for Years 2014, 2023 & 2030
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    by Type - Lithium ion Battery, Lead Acid Battery and Other
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    by End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Battery Electric Vehicles for the Years 2014, 2023 & 2030
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    by Type - Lithium ion Battery, Lead Acid Battery and Other
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    by End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Battery Electric Vehicles for the Years 2014, 2023 & 2030
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    by Type - Lithium ion Battery, Lead Acid Battery and Other
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    by End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Battery Electric Vehicles for the Years 2014, 2023 & 2030
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    Type - Lithium ion Battery, Lead Acid Battery and Other Types
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Battery Electric Vehicles for the Years 2014, 2023 & 2030
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    Type - Lithium ion Battery, Lead Acid Battery and Other Types
    Battery, Lead Acid Battery and Other Types for the Years 2014,
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Electric Vehicles for the Years 2014, 2023 & 2030
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    Type - Lithium ion Battery, Lead Acid Battery and Other Types
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Battery Electric Vehicles for the Years 2014, 2023 & 2030
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead
    by Type - Lithium ion Battery, Lead Acid Battery and Other
    Electric Vehicle Battery by End-Use - Hybrid Electric Vehicles,
    by End-Use - Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Battery Electric Vehicles for the Years 2014, 2023 & 2030
    Table 92: Rest of Europe Recent Past, Current & Future Analysis
    for Electric Vehicle Battery by Type - Lithium ion Battery,
    Battery by Type - Lithium ion Battery, Lead Acid Battery and
    Table 95: Rest of Europe Recent Past, Current & Future Analysis
    Battery by End-Use - Hybrid Electric Vehicles, Plug-in Hybrid
    Sales for Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Vehicles and Battery Electric Vehicles for the Years 2014, 2023 &
    for Electric Vehicle Battery by Geographic Region - Australia,
    Battery by Geographic Region - Australia, India, South Korea
    Asia-Pacific Markets for Years 2014, 2023 & 2030
    for Electric Vehicle Battery by Type - Lithium ion Battery,
    Battery by Type - Lithium ion Battery, Lead Acid Battery and
    Battery by End-Use - Hybrid Electric Vehicles, Plug-in Hybrid
    Sales for Hybrid Electric Vehicles, Plug-in Hybrid Electric
    Vehicles and Battery Electric Vehicles for the Years 2014, 2023 &
    Electric Vehicle Battery by Type - Lithium ion Battery, Lead

Electric Vehicle Battery Market is expected to grow at 8.5% CAGR from 2022 to 2032 - Future Market Insights, Inc.

Retrieved on: 
Thursday, September 15, 2022
Observation, Adoption, BEV, Carbon, HEV, Toshiba, BYD Company, Organization, Growth, Panasonic, Hybrid electric vehicle, Industry, EVS, Maintenance, Environment, Automotive Energy Supply Corporation, Wanxiang, LG Chem, Running, Technology, Kilowatt-hour, FMI, Electric vehicle battery, PHEV, EV, KSR International Co. v. Teleflex Inc., Johnson Controls, CAGR, Lithium, Renewable energy, Taxicab, Airline, EnerSys

NEWARK, Del., Sept. 15, 2022 /PRNewswire/ -- The global electric vehicle battery market is anticipated to reach a valuation of US$ 18.09 Bn in 2032, with the market growing at a positive CAGR of 8.5% over the forecast period of 2022 to 2032. Scaling up from an estimated US$ 8.68 Bn in 2022, the electric vehicle market is driven by technological advancements, the growing usage of lithium-ion batteries, and increasing fuel prices. A surge in the sales of hybrid/ electric vehicles also augment the market growth of electric vehicle batteries during this period.

Key Points: 
  • Expanding Electric Vehicle (E-Vehicle) Sector Presents Opportunity worth US$ 18.09 Bn for Electric Vehicle Battery by 2032.
  • The dominance of HEV over PHEV and BEV in the electric vehicle market makes them the prominent market for electric vehicle battery.
  • NEWARK, Del., Sept. 15, 2022 /PRNewswire/ -- The global electric vehicle battery market is anticipated to reach a valuation of US$ 18.09 Bn in 2032, with the market growing at a positive CAGR of 8.5% over the forecast period of 2022 to 2032.
  • A surge in the sales of hybrid/ electric vehicles also augment the market growth of electric vehicle batteries during this period.

Electric Vehicle Battery Market is expected to grow at 8.5% CAGR from 2022 to 2032 - Future Market Insights, Inc.

Retrieved on: 
Thursday, September 15, 2022
Observation, Adoption, BEV, Carbon, HEV, Toshiba, BYD Company, Organization, Growth, Panasonic, Hybrid electric vehicle, Industry, EVS, Maintenance, Environment, Automotive Energy Supply Corporation, Wanxiang, LG Chem, Running, Technology, Kilowatt-hour, FMI, Electric vehicle battery, PHEV, EV, KSR International Co. v. Teleflex Inc., Johnson Controls, CAGR, Lithium, Renewable energy, Taxicab, Airline, EnerSys

NEWARK, Del., Sept. 15, 2022 /PRNewswire/ -- The global electric vehicle battery market is anticipated to reach a valuation of US$ 18.09 Bn in 2032, with the market growing at a positive CAGR of 8.5% over the forecast period of 2022 to 2032. Scaling up from an estimated US$ 8.68 Bn in 2022, the electric vehicle market is driven by technological advancements, the growing usage of lithium-ion batteries, and increasing fuel prices. A surge in the sales of hybrid/ electric vehicles also augment the market growth of electric vehicle batteries during this period.

Key Points: 
  • Expanding Electric Vehicle (E-Vehicle) Sector Presents Opportunity worth US$ 18.09 Bn for Electric Vehicle Battery by 2032.
  • The dominance of HEV over PHEV and BEV in the electric vehicle market makes them the prominent market for electric vehicle battery.
  • NEWARK, Del., Sept. 15, 2022 /PRNewswire/ -- The global electric vehicle battery market is anticipated to reach a valuation of US$ 18.09 Bn in 2032, with the market growing at a positive CAGR of 8.5% over the forecast period of 2022 to 2032.
  • A surge in the sales of hybrid/ electric vehicles also augment the market growth of electric vehicle batteries during this period.

New Analysis from Global Industry Analysts Reveals Steady Growth for Implantable Ports, with the Market to Reach $233.2 Million Worldwide by 2026

Retrieved on: 
Monday, June 27, 2022
Research, Intelligence, Marketing, COVID-19, Growth, Forecasting, KSR International Co. v. Teleflex Inc., GIA, Internet, SAN, CAGR, Players, BARD, Pet, Pharmaceutical industry

SAN FRANCISCO, June 27, 2022 /PRNewswire/ --A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Implantable Ports - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, June 27, 2022 /PRNewswire/ --A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Implantable Ports - Global Market Trajectory & Analytics" .
  • Geographies:World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
  • Preview Registry
    Amid the COVID-19 crisis, the global market for Implantable Ports estimated at US$196.2 Million, is projected to reach a revised size of US$233.2 Million by 2026, growing at a CAGR of 2.9% over the analysis period.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Global Industry Analysts Predicts the World Airway Management Devices Market to Reach $2.2 Billion by 2026

Retrieved on: 
Thursday, March 3, 2022
ConvaTec, Intelligence, Investment, Airway management, Preterm birth, Medtronic, Cardiopulmonary resuscitation, COVID-19, Nasopharyngeal airway, Oropharyngeal airway, ICU, Laryngoscopy, Tongue, Resuscitator, KARL, Ageing, Players, GIA, FROPVD, Asthma, Emergency medicine, Solution, SAN, Glottis, Incidence, Forecasting, Hospital, Blood, Marketing, Fluid mechanics, Foreign Bodies, Medline Industries, KSR International Co. v. Teleflex Inc., Anesthesiology, Patient, Research, Prevalence, Safety, Internet, Mouth, Growth, SunMed BRT station, COPD, CAGR, Degenerative disease, Trachea, Pharmaceutical industry, Pet, Airline, Others, Anesthesia, Flexicar (carsharing)

SAN FRANCISCO, March 3, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Airway Management Devices - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, March 3, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Airway Management Devices - Global Market Trajectory & Analytics" .
  • The use of advanced devices such as supraglottic airway in preoperative airway evaluation is expected to increase the demand for airway management devices.
  • Airway management market continues to witness the rising proliferation of more advanced airway management devices.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

DGAP-News: Mainz Biomed Engages DCN Dx to Support Clinical Study Evaluating Novel mRNA Biomarkers for Potential Integration into ColoAlert

Retrieved on: 
Wednesday, January 19, 2022
Biomarker, PCR, CRC, Private Securities Litigation Reform Act, SEC, TTS, NASDAQ, Death, U.S. Securities and Exchange Commission, Infection, KSR International Co. v. Teleflex Inc., Cancer, Compliance, Colon, STD, Real-time polymerase chain reaction, Teleflex, Union, COVID-19, Colorectal cancer, Clinical research, American Cancer Society, Company, FDA, Ageing, Forward-looking statement, Patient, FIT, Data management, DNA, Health, Roche Diagnostics, News, Neoplasm, Prospectus, RNA transfection, Trial of the century, Large intestine, BS, AA, Biostatistics, IVDR, DGAP, CRO, Security (finance), Medical device, Vaccine, Pharmaceutical industry, EU, Microbiology, Biology

Under the terms of the engagement, DCN Dx will be responsible for the selection of additional clinical research organizations (CRO) and assist Mainz's management with the development of robust study protocols and associated clinical processes.

Key Points: 
  • Under the terms of the engagement, DCN Dx will be responsible for the selection of additional clinical research organizations (CRO) and assist Mainz's management with the development of robust study protocols and associated clinical processes.
  • Emily brings to the project over 20 years of clinical research experience as a scientist and executive.
  • Mainz Biomed currently distributes ColoAlert through a number of clinical affiliates.
  • DCN Dx provides end-to-end support for rapid diagnostic test development and production in an array of applications.

Mainz Biomed Engages DCN Dx to Support Clinical Study Evaluating Novel mRNA Biomarkers for Potential Integration into ColoAlert

Retrieved on: 
Wednesday, January 19, 2022
Real-time polymerase chain reaction, PCR, Biomarker, BS, Patient, Ageing, FIT, Forward-looking statement, AA, Data management, Teleflex, CRC, Private Securities Litigation Reform Act, Union, SEC, COVID-19, Colorectal cancer, Biostatistics, NASDAQ, Death, Trial of the century, GLOBE, DNA, IVDR, Clinical research, Health, U.S. Securities and Exchange Commission, Infection, Roche Diagnostics, KSR International Co. v. Teleflex Inc., American Cancer Society, CRO, Company, Cancer, Neoplasm, FDA, Compliance, Prospectus, Security (finance), RNA transfection, Colon, Large intestine, STD, Medical device, Medical imaging, Pharmaceutical industry, Vaccine, EU, Microbiology, Biology

BERKELEY, Calif. and MAINZ, Germany, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today it has formally contracted with DCN Dx, a leading international developer of point-of-care diagnostics, and provider of comprehensive product development services. An integral part of the engagement will be the role of Emily Friedland, Vice President of Clinical Research at DCN Dx, who will spearhead the preparation and initiation of Mainz’s European centric clinical study to evaluate the potential to integrate a portfolio of recently acquired novel mRNA biomarkers into ColoAlert, the Company’s highly efficacious, and easy-to-use detection test for colorectal cancer. This suite of biomarkers which were in-licensed from Socpra Sciences Santé Et Humaines S.E.C. (“TTS”) in early January 2022, have demonstrated the unique ability to detect pre-cancerous lesions including advanced adenomas (AA), a type of pre-cancerous polyp often attributed to colorectal cancer (CRC). The study is on track to commence in the first half of 2022.

Key Points: 
  • Under the terms of the engagement, DCN Dx will be responsible for the selection of additional clinical research organizations (CRO) and assist Mainzs management with the development of robust study protocols and associated clinical processes.
  • Emily brings to the project over 20 years of clinical research experience as a scientist and executive.
  • Mainz Biomed currently distributes ColoAlert through a number of clinical affiliates.
  • With DCN Dx, clients receive the products and development, design, manufacturing, and commercialization expertise they need to meet their rapid diagnostic milestones.